Differentiation of mouse embryonic stem (ES) cells via embryoid bodies was established as a suitable model to study development in vitro. Here, we show that differentiation of ES cells in vitro into chondrocytes can be modulated by members of the transforming growth factor-b family (TGF-b 1 , BMP-2 and -4). ES cell differentiation into chondrocytes was characterized by the appearance of Alcian blue-stained areas and the expression of cartilage-associated genes and proteins. Different stages of cartilage differentiation could be distinguished according to the expression pattern of the transcription factor scleraxis, and the cartilage matrix protein collagen II. The number of Alcian-blue-stained areas decreased slightly after application of TGF-b 1 , whereas BMP-2 or -4 induced chondrogenic differentiation. The inducing effect of BMP-2 was found to be dependent on the time of application, consistent with its role to recruit precursor cells to the chondrogenic fate. q
Introduction
Whereas structure and function of the mature cartilage matrix is well characterized, there is only limited knowledge about the commitment of mesenchymal cells to differentiate into cartilage or bone. The mammalian skull is, with exception of the craniofacial bones, of mesodermal origin. Mesenchymal cells originating from the somitic mesoderm form the bones of the axial skeleton and mesenchymal cells from the lateral mesoderm the skeleton of the extremities (Erlebacher et al., 1995) . After aggregation, mesenchymal cells follow the process of chondrogenesis resulting in bone formation (Poole, 1991) . Several transcription factors are known to be involved in early determination of mesenchymal cells into the chondrogenic lineage. For example, the spatio-temporally controlled expression of the mouse homeobox-gene clusters Hox-A, -B, -C and -D is known to play a pivotal role during skeletal differentiation (Krumlauf, 1993 (Krumlauf, , 1994 Morgan and Tabin, 1994) . Further transcription factors expressed in mesenchymal cells during early stages of chondrogenesis are for example the basic-helix-loophelix (bHLH) protein scleraxis (Cserjesi et al., 1995) , the high-mobility-group (HMG) box protein Sox-9 (Wright et al., 1995) and the paired-box-gene Pax-1 (Deutsch et al., 1988; Wallin et al., 1994) .
Local induction-processes play an important role during skeletal development. For craniofacial bone development (Langille, 1994) and formation of bones in limb buds (Laufer et al., 1994; Niswander et al., 1994) epithelialmesenchymal cell interactions are necessary. Development of the axial skeleton is based on interactions between the notochord and the sclerotome (Brand-Saberi et al., 1993; Fan and Tessier-Lavigne, 1994) . Signaling molecules such as ®broblast growth factor (FGF)-2, sonic hedgehog (SHH) and Wnt-7a play a decisive role during these processes (Riley et al., 1993; Fallon et al., 1994; Fan and TessierLavigne, 1994, Laufer et al., 1994; Niswander et al., 1994; Cohn et al., 1995; Parr and McMahon, 1995; Vogel et al., 1995 Vogel et al., , 1996 . Furthermore, members of the transforming growth factor-b (TGF-b ) family (Kulyk et al., 1989; Leonard et al., 1991; Wozney, 1992; Frenz et al., 1994; Roark and Greer, 1994; Rosen et al., 1994; Ganan et al., 1996) including TGF-b 1 and bone morphogenetic proteins-2 and -4 (BMP-2 and -4) have the potency to in¯uence development of cartilage and bone.
In vitro systems used to study chondrogenesis are primary cultures of adult or embryonic cartilage tissue and cell lines of mesenchymal origin (Ahrens et al., 1993; Laitinen et al., 1999; Lou et al., 1999) or mesenchymal stem cells derived from bone marrow (Mackay et al., 1998) . However, these cell systems are limited for studies of early differentiation because they represent already determined and differentiated cells. Another hindrance is the progressive dedifferentiation of cells of this origin (von der Mark et al., 1977) . An alternative approach is offered by the differentiation of pluripotent mouse embryonic stem (ES) cells. ES cells have the capacity to differentiate into cells of all three primary germlayers due to their origin from the inner cell mass of early embryos (Evans and Kaufmann, 1981; Martin, 1981) . In vivo, ES cells are used to generate mice carrying loss of function mutations by gene-targeting via homologous recombination (Thomas and Capecchi, 1987) . In vitro, ES cells differentiate via embryoid bodies (EBs) into various cell types (Wobus et al., 1984; Doetschman et al., 1985) . It has been shown that differentiation of ES cells into a variety of cell types rather closely recapitulates embryonic development (Rohwedel et al., , 1998a Wobus et al., 1997a,b; Wobus and Guan, 1998) . Accordingly, this cell system has been used to study the differentiation of cardiogenic (Wobus et al., 1991; Miller-Hance et al., 1993; Maltsev et al., 1993 Maltsev et al., , 1994 , myogenic (Rohwedel et al., , 1998a Rose et al., 1994) , hematopoietic (Schmitt et al., 1991; Wiles and Keller, 1991; Potocnik et al., 1994) , neurogenic (Bain et al., 1995; Fraichard et al., 1995; Stru Èb-ing et al., 1995) , epithelial (Bagutti et al., 1996) , vascular smooth muscle (Drab et al., 1997) and adipogenic (Dani et al., 1997) cells (reviewed by Keller, 1995; Wobus et al., 1997b; Rathjen et al., 1998; Guan et al., 1999) .
Here, we demonstrate that mouse ES cells differentiate in vitro into chondrocytes evidenced by the expression of cartilage associated genes and proteins. Moreover, we show that members of the TGF-b growth factor family modulate ES cell-derived chondrogenic differentiation in a time-dependent manner.
Results

ES cells differentiate into chondrogenic cells in vitro
In EB outgrowths derived from ES cell line D3 many Alcian blue-stained regions were found, indicating the presence of acidic proteoglycans suggestive for cartilaginous tissue. The ®rst Alcian blue positive areas were detected 4 days after plating of EBs (`5 1 4 d') and their number increased during ongoing cultivation (Fig. 1 ). Light and deep Alcian blue-stained areas were distinguished, the latter of which appeared later, usually beginning between 2 and 3 weeks after plating of EBs. These deeply stained areas contained collagenous matrix as revealed by AFG staining and contained a dense group of round-shaped cells (Fig.  2A±C ). Cells in these areas produced collagen II and cartilage oligomeric matrix protein (COMP) as demonstrated by Fig. 1 . The number of Alcian blue-stained areas increased during differentiation of ES cells in vitro. Five-day-old embryoid bodies (EBs) were plated, stained with Alcian blue at different times from 2 up to 29 days after plating and the number of stained areas in individual EBs was counted. Four days after plating (`5 1 4 d') the ®rst stained areas were detected and their number increased during further cultivation. Ten EBs were analyzed at each day. Mean values^SD are shown. The inset shows Alcian blue-stained areas in a`5 1 21 d' EB outgrowth (bar 100 mm).
immunostaining (Fig. 2D±F ). The number of Alcian bluestained areas appearing in EB outgrowths was found to be in¯uenced by the amount of cells used for EB formation. Among the EBs prepared from 200, 500 and 800 cells the highest number of Alcian-blue-stained areas was detected in outgrowths of EBs derived from 800 cells (data not shown). Therefore, 800 cells per EB were used during this study.
Cartilage associated genes are expressed during ES cell differentiation in vitro
Semiquantitative reverse transcriptase±polymerase chain reaction (RT±PCR) analysis demonstrated that genes encoding transcription factors involved in mesenchymal differentiation, such as Pax-1 and Sox-9 as well as extracellular matrix proteins of cartilage tissue, such as collagen II and aggrecan were found to be expressed in EBs during culture (Fig. 3) . RNA isolated from whole EBs was analyzed. The expression levels of Pax-1 and Sox-9 showed only minor changes during cultivation time analyzed from`5 1 4 d' until`5 1 28 d'. Even less differences were observed in the expression level of aggrecan. In contrast, expression of the collagen II splice variant A was upregulated during EB cultivation. Signi®cant differences in the expression levels were detected between 4 and 7 compared to 21 days after EB plating (P 0:02 and P 0:01, respectively). Faint bands were ampli®ed from the adult splice variant B of collagen II from`5 1 10 d' up to`5 1 28 d'. These results con®rm the differentiation of ES cells into chondrocytes on the gene expression level.
Distinct stages of chondrogenic differentiation as revealed by coexpression of scleraxis and collagen II
During mouse embryogenesis, the transcription factor scleraxis is expressed at high levels in mesenchymal cell condensations that form later on cartilage tissues and is thought to activate cartilage-speci®c genes such as collagen II (Cserjesi et al., 1995) . The temporal and spatial expression pattern of scleraxis was therefore analyzed during EB differentiation by RT±PCR and in situ hybridization.
RT±PCR analysis revealed a characteristic temporal expression pattern of scleraxis (Fig. 4A,B) . Scleraxis was ®rst expressed at a high level at`5 1 2 d' and was downregulated at`5 1 4 d' (P 0:004). Expression of scleraxis was upregulated thereafter from`5 1 7 d' up to`5 1 16 d'. In comparison to the high expression on`5 1 2 d' and 5 1 10 d' expression declined at`5 1 18 d' (P 0:03 and P 0:01, respectively) and was upregulated again at 5 1 28 d' (P 0:017). In situ hybridization for scleraxis con®rmed the results obtained by RT±PCR analysis. In combination with immunostaining against collagen II, in situ hybridization demonstrated colocalization of scleraxis transcripts and collagen II protein. Up to 6 days after EB plating, high expression of scleraxis was restricted to cells organized in streaks in EB outgrowths (Fig. 5A ). During this time, collagen II could not be detected (Fig. 5E ). Between 7 and 16 days after plating, scleraxis was expressed in large areas of cells also expressing collagen II, often assembled as ®brillar structures (Fig. 5B,F ). Up to this stage, scleraxis expressing cells were morphologically indistinguishable from neighboring cells as analyzed by interference contrast microscopy ( Fig. 5I ,J). Compact and distinct cellular entities were observed at about`5 1 17 d' (Fig. 5K ) consisting of cells positively stained for scleraxis transcripts and for collagen II protein (Fig. 5C ,G). During further cultivation, the size of these cell formations increased and they developed into dense aggregates, while the cells showed an increasing level of scleraxis expression (Fig. 5D ,L). These nodules were surrounded by a membranous structure containing collagen II (Fig. 5H ) and showed intensive Alcian blue staining and expression of COMP (see Fig. 2 ). In addition to the described cell areas with high expression of scleraxis, some cell types were observed during EB differentiation that showed a low expression level. . Scleraxis gene expression is developmentally regulated during ES cell differentiation. Total RNA extracted from EBs was reverse transcribed and PCR ampli®ed using primers speci®c for the transcription factor scleraxis (Scl) and the housekeeping gene hypoxanthine guanine phosphoribosyl transferase (HPRT). PCR ampli®ed fragments separated by gel electrophoresis are shown (A). The ratio of scleraxis relative to HPRT is indicated (B). Mean values^SD derived from independent experiments (n 4) are shown.
However, these cells did not express collagen II (data not shown). A sense probe generated from the scleraxis cDNA did not hybridize speci®cally to any cell types.
ES cell-derived chondrogenesis is modulated by growth factors of the TGF-b family
Treatment of EBs with 2 ng/ml TGF-b 1 from`1 d' up tò 5 1 30 d' resulted in a slight decrease of Alcian bluestained areas of about 33% at`5 1 29 d' compared to untreated control EBs (Fig. 6A) . When BMP-2 was applied at a concentration of 2 ng/ml to the EBs during the entire culture time from`1 d' up to`5 1 30 d', an increase of Alcian blue-stained areas per EB was found (Fig. 6A) . At 5 1 27 d', the BMP-2 treated EBs showed an approximately 2-fold higher amount of Alcian blue positive areas compared to the untreated control. The enhancing effect was ®rst detected after approximately three weeks of differentiation (`5 1 22 d'). BMP-4 treatment from`1 d' up to`5 1 30 d' of EB cultivation resulted in an approximately 2.5-fold enhancement of Alcian blue-stained areas at`5 1 30 d' (Fig. 6B) . Again, a difference to the control was ®rst observed after approximately 3 weeks of cultivation (`5 1 20 d'). No obvious differences in the size or growth rate of EBs cultivated in the presence or absence of growth factors were observed.
Immunostaining showed that only some of the Alcian blue-stained cells expressed collagen II. This might be caused by an earlier onset of proteoglycan expression in relation to collagen II and/or by non-cartilage cells expressing Alcian blue-stained proteoglycans. Therefore, in addition to Alcian blue staining, collagen II immunostaining of growth factor treated and control EBs was performed. This analysis showed that the number of collagen II-positive areas declined slightly after treatment with TGF-b 1 (Fig.  6C ), whereas treatment with BMP-2 (Fig. 6C ) and with 
BMP-2 time-dependently enhanced chondrogenic differentiation
The effect of BMP-2 to enhance the development of chondrogenic cells during ES cell differentiation was found to be dependent on the time of application. When BMP-2 was applied during cultivation of EBs in suspension (`2±5 d') an increase of Alcian blue-stained areas was obtained (Fig. 7A) . In contrast, when BMP-2 was applied either during hanging drop culture (`0±2 d') or after plating of EBs (`5±5 1 4 d') no difference to the control regarding the development of Alcian blue-stained areas was found. Immunostaining for collagen II was in accordance with these observations (Fig. 7B) . BMP-2 only led to an increase in the number of collagen II positive areas when applied during EB development from day 2 to 5. The two other conditions, application of BMP-2 from`0±2 d' and from 5±5 1 4 d' did not cause any differences to the control regarding the differentiation of collagen II positive cells.
Discussion
ES cell-derived chondrogenesis is developmentally regulated
Our study demonstrated that ES cells cultivated via EBs have the potency to differentiate into chondrogenic cells, as shown by the appearance of Alcian blue-stained nodules and expression of collagen II and COMP. In addition, the cartilage associated genes scleraxis, Pax-1, Sox 9, collagen II and aggrecan were found to be expressed.
Numerous studies with a focus on differentiation of chondrogenic and osteogenic cells in vitro were performed on primary cultures, tumor cell lines and mesenchymal cell lines (Ahrens et al., 1993; Mackay et al., 1998; Laitinen et al., 1999; Lou et al., 1999;  for review see Erlebacher et al., 1995) . These in vitro cell systems are based on cells originating from adult or embryonic tissues, with differentiated and determined cells. Accordingly, the analysis of differentiation was restricted to relatively late stages of development (Castagnola et al., 1988; Bruckner et al., 1989; Galotto et al., 1994) . In contrast, the ES cell model includes all stages of differentiation, starting with pluripotent cells that become committed to the mesenchymal lineage and develop into terminally differentiated cells. Thereby, ES cell differentiation in vitro closely recapitulates developmental processes in vivo (Guan et al., 1999) . In addition, the ES cell model system offers the possibility to perform loss-of-function (Braun and Arnold, 1994; Fa Èssler et al., 1996; Rohwedel et al., 1998b ; reviewed by Rathjen et al., 1998) as well as gain-of-function analyses (Rohwedel et al., 1995; Dinsmore et al., 1996; Helgason et al., 1996) in vitro, impossible to carry out in other in vitro systems of chondrogenesis.
We studied expression of scleraxis during EB differentiation using in situ hybridization, since this gene is known to be expressed in the sclerotome and in mesenchymal cells during mouse embryogenesis, foreshadowing the developing cartilaginous skeleton (Cserjesi et al., 1995) . Scleraxis is ®rst expressed throughout the embryo at the time of gastrulation before becoming restricted to mesenchymal precursors in advance of chondrogenesis (Brown et al., 1999) . Later it is downregulated and comes up again in cartilage tissue (Cserjesi et al., 1995) . During early EB differentiation we found high levels of scleraxis expression in cells that did not produce collagen II and later scleraxis expressing cells were organized in nodules staining positive for Alcian blue, collagen II and COMP characteristic for developing chondrocytes. Furthermore, we found that expression of the juvenile splice variant A of collagen II was upregulated during EB differentiation. Taken together, these results indicate a regulated process of chondrogenesis during EB differentiation. In addition, we tested for Alcian blue staining as a parameter of chondrogenic differentiation. Alcian blue stains acidic proteoglycans speci®cally expressed in cartilage (Steedman, 1950) . However, we found that only some of the Alcian blue-stained areas also contained collagen II. A possible explanation may be that expression of collagen II protein lacks behind expression of Alcian blue-stainable proteoglycans and/or that some of the stained areas contained proteoglycans expressed by other cell types than chondrocytes.
Growth factors of the TGF-b family modulate ES cellderived chondrogenesis
Our data show that TGF-b 1 treatment resulted in unaltered or slightly reduced ES cell-derived chondrogenic differentiation. In contrast, when tested on primary chondrocytes, TGF-b 1 enhanced the level of expression of cartilage speci®c markers (Luyten et al., 1994; Qi and Scully, 1998) . However, it has also been shown that chondrocytes treated with TGF-b 1 proliferated into cells with a ®broblas-tic morphology paralleled by a decrease of proteoglycan and collagen II synthesis (Bradham et al., 1994) . Moreover, it has been shown that TGF-b 1 alone was not a suf®cient stimulus to initiate chondrogenesis in cultured periotic mesenchyme (Frenz et al., 1994) . Studies about the in¯u-ence of growth factors on differentiation should be performed under serum-free conditions whereas we used selected batches of serum. This was necessary because mesodermal differentiation of ES cells is almost completely inhibited under serum-free conditions (Wobus, unpublished results) , possibly because differentiation into neuronal cells is a default fate of embryonic cells under inhibitory control Fig. 7 . The effect of BMP-2 to enhance chondrogenic differentiation during ES cell differentiation was found to depend on the stage of application. BMP-2 was applied during different stages of embryoid development: during hanging drop culture from 0 to 2 day (`0±2 d'), during EB cultivation in suspension from 2 to 5 day (`2±5 d') and after EB plating from 5 to 5 1 4 day (`5±5 1 4 d'). The number of Alcian blue-stained areas was counted during further EB cultivation. Only when BMP-2 was applied during`2±5 d' was the enhancing effect observed (A). Immunostaining for collagen II con®rmed that the stimulatory effect of BMP-2 was particularly prominent when applied from 2 to 5-days (B). Mean values^SD are shown. Signi®-cant differences (in comparison to untreated control cells): *P # 0:05; **P # 0:01; ***P # 0:001. of mesoderm-inducing factors (Hemmati-Brivanlou and Melton, 1997) .
According to our data, we propose BMP-2 and -4 as early inducers of chondrogenic differentiation. These results are in line with reports showing that BMPs induced the formation of new cartilage and bone in vivo when implanted subcutaneously (Reddi and Cunningham, 1993; Reddi, 1994) or in muscle tissue (Ku Èbler et al., 1998) . Furthermore, BMP-2 and -4 induced differentiation of murine mesenchymal progenitor cells into osteogenic cells as well as into chondrocytes and adipocytes (Ahrens et al., 1993) . The mesenchymal cell line C3H10T1/2 differentiates into the chondrogenic lineage after treatment with BMP-2 (Haas and Tuan, 1999) , and BMP-2 and -4 were found to be responsible for the initiation of both cartilage and bone cell lineages (Wozney, 1992; Duprez et al., 1996) .
BMP-2 stage-dependently enhanced chondrogenic differentiation
We observed a time-dependent effect of BMP-2 to increase chondrogenic differentiation limited to a time window between 2 and 5 days of EB development. This early stage of ES cell differentiation is a period of early mesodermal development characterized by the expression of Brachyury and BMP-4 (Yamada et al., 1994; Johansson and Wiles, 1995; Rohwedel et al., 1998b) . Previous studies have shown that this stage of early mesodermal differentiation is also susceptible for the in¯uence of other differentiation factors, such as retinoic acid (RA). Along these lines, treatment of ES cell-derived EBs with RA from day 2 to 5 resulted in induction of skeletal muscle cells and adipocytes (Dani et al., 1997) , but inhibition of cardiogenesis . Together, these results indicate that speci®cation of mesodermal cells into precursors of different lineages may occur during this early stage of EB differentiation and that BMP-2 plays a pivotal role to induce precursor cells to the chondrogenic fate.
Future prospects of in vitro chondrogenesis
Chondrocytes derived from ES cells could have the advantage to obtain a stable phenotype compared to chondrogenic cells derived from primary cultures, which progressively dedifferentiate (von der Mark et al., 1977) . A similar notion can be deduced from experiments demonstrating that ES-cell-derived cardiac cells showed specialization into ventricular, atrial and sinusoidal cells (Maltsev et al., 1993 in contrast to the fast dedifferentiation of cardiac cells originating from primary cultures (Claycomb and Palazzo, 1980; Nag et al., 1983; Sperelakis and Pappano, 1983; Bugaisky and Zak, 1989) . Extending the ES cell model system to human ES cell lines that are now available (Shamblott et al., 1998; Thomson et al., 1998) , chondrocytes derived from ES cells may be suitable for in vivo transplantations in pathological conditions such as osteoarthrosis. Methods to obtain transplantable differentiated cell types from mouse ES cells have already been published (Dinsmore et al., 1996; Klug et al., 1996; Bru Èstle et al., 1999) . The ES cell system could serve as an alternative to mesenchymal stem cells. These cells have the potency to differentiate into several cell types (Pittenger et al., 1999) and have already been used for cartilage and bone repair in animals (Caplan et al., 1997; Bruder et al., 1998) as well as humans (Horwitz et al., 1999) .
In conclusion, our results show, that ES cells differentiate into chondrocytes in vitro. Furthermore, we show, that this process can be modulated by growth factors of the TGF-b family. Thus, this model system might be useful for studying early chondrogenesis, especially when combined with gene inactivation by gene targeting via homologous recombination in ES cells. Furthermore, this cellular differentiation system could be suitable to delineate as yet unknown genes or signaling molecules which take part in early chondrogenic differentiation. In this context, one has to consider that EBs contain a variety of differentiated cell types. To obtain homogeneous cell populations, ES cells could either be induced with differentiation factors (Dinsmore et al., 1996; Bru Èstle et al., 1999) or transfected with vectors that enable selective differentiation (Klug et al., 1996) . Finally, the protocol described here could be useful to differentiate human ES cells into chondrocytes which could be applied for repair of cartilage defects.
Experimental procedures
Cell culture and differentiation of EBs
ES cells of line D3 (Doetschman et al., 1985) were cultivated on a feeder-layer of Mitomycin C-inactivated mouse embryonic ®broblasts in cultivation medium consisting of Dulbecco's modi®ed Eagle's medium (DMEM; Life Technologies, Eggenstein, Germany) supplemented with 15% fetal calf serum (FCS, selected batches, Life Technologies), 2 mM l-glutamine (Life Technologies), 5 £ 10 25 M bmercaptoethanol (Serva, Heidelberg, Germany), non-essential amino acids (Life Technologies, stock solution diluted 1:100) as described previously (Wobus et al., 1988 (Wobus et al., , 1991 . For differentiation, aliquots of 20 ml differentiation medium (with 20% FCS instead of 15%) containing 200, 500 or 800 cells were cultivated in`hanging drops' for 2 days and subsequently in suspension on bacteriological petri dishes for additional 3 days as described . The 5-day-old (`5 d') EBs were plated separately onto gelatin (0.1%)-coated 24 well microwell plates for morphological analysis, onto 6 cm tissue culture plates for Alcian blue staining and RT±PCR and onto 2-well (21:3 £ 20 mm) LabTek chamber slides (NUNC, Wiesbaden, Germany) for immunostaining, in situ hybridization and Aldehyde-Fuchsin-Goldner (AFG) staining. AFG and Alcian blue stainings were performed using standard methods (Romeis, 1989) . EBs were plated, stained with Alcian blue at different times and the number of stained areas in individual EBs was counted. To study growth factor-induced modulation of ES cell-derived chondrogenesis, BMP-2 (2 ng/ml; 10 ng/ml), BMP-4 (10 ng/ml) and TGF-b 1 (2 ng/ml) were added to the culture medium during different stages of EB development and differentiation was compared to control cultures without growth factors. The concentrations of the growth factors used are in the range previously shown to be suf®cient to in¯uence chondrogenic differentiation in other cell systems (Carrington and Reddi, 1990; Chen et al., 1991; Downie and Newman, 1994; Luyten et al., 1994; Erickson et al., 1997) . BMP-2 and BMP-4 were recombinant human proteins obtained as a gift from Genetics Institute (Cambridge, MA, USA), TGF-b 1 was the native protein isolated from human platelets (Tebu, Frankfurt, Germany) .
Experiments were done at least in triplicate and data analysis was performed using the Sigma Plot 5.0 software (Jandel, Corte Madeira, CA, USA). For statistical analysis the Student's t-test was used.
Detection of gene expression by semiquantitative RT± PCR analysis
Samples of ten EBs of different developmental stages were collected, washed twice with phosphate-buffered saline (PBS), and total RNA was isolated using the RNeasy Mini-Kit (Qiagen, Hilden, Germany). The RNA concentrations were determined by measuring the absorbance at 260 nm. Samples of 500 ng of RNA were reverse transcribed using oligo-dT primer and Superscript II reverse transcriptase following the manufacturers recommendations (Life Technologies).
Aliquots of 1 ml from the RT reactions were used for ampli®cation of transcripts using primers speci®c for the analyzed genes and Vent DNA polymerase (New England Biolabs, Schwalbach, Germany) according to the manufacturer's instructions. RT-reactions were denatured for 2 min at 958C, followed by 34±45 cycles of 40 s denaturation at 958C, 40 s annealing at the primer speci®c temperature (see below) and 50 s elongation at 728C. Expression of the following genes was studied (oligonucleotide sequences are given in brackets in the order antisense-, sense-primer followed by the annealing temperature used for PCR, length of the ampli®ed fragment and a reference): Genes encoding the transcription factors scleraxis (5
H ; 638C; 375 bp; Cserjesi et al., 1995) Konecki et al., 1982) , both used as internal standards. For RT±PCR analysis of scleraxis we used the protocol by Wong et al. (1994) , including the oligonucleotide primer for HPRT and scleraxis in the same reaction (Wobus et al., 1997a) . Electrophoretic separation of PCR products was carried out on 2% agarose gels. The fragments were analyzed by computer-assisted densitometry in relation to HPRT or b-tubulin gene expression. RNA from limb buds or limbs of 10-and 16-day post-coitus (p.c.) mouse embryos were used as positive controls. Distilled water was always included as a negative control.
Immunostaining
EBs cultivated on chamber slides were rinsed two times in PBS, ®xed for 5 min with methanol:acetone (7:3) at 2208C, rinsed three times in PBS again and incubated for 15 min in 10% goat serum at room temperature. Specimens were then incubated with the primary antibodies for 1 h at 378C in a humidi®ed chamber. Immunostaining for cartilage oligo matrix protein (COMP; Hedbom et al., 1992) was performed with a polyclonal antiserum and for detection of collagen II the monoclonal antibody II-II6B3 (Linsenmayer and Hendrix, 1980; obtained from the Developmental Studies Hybridoma Bank, University of Iowa, USA) was used. Both antibodies were used at a 1:20 dilution. After rinsing three times with PBS, slides were incubated for 45 min at 378C with either, FITC-or Cy3-labeled anti-mouse IgG (Dianova, Hamburg, Germany), both diluted 1:200. Slides were then washed three times in PBS. After a ®nal wash in distilled water, specimens were embedded in Vectashield mounting medium (Vector, Burlingame, CA, USA) and analyzed with an Axioskop¯uorescence microscope (Zeiss). For studying the effect of growth factors, the number of immunostained areas in individual EBs at different times after EB plating was counted.
Fluorescence in situ hybridization for scleraxis coupled with immunostaining against collagen II
For¯uorescence in situ hybridization we used a modi®ed procedure of Yamada et al. (1994) . Ten EBs were plated per chamber slide and analyzed at different developmental stages. The chamber slides were rinsed twice with PBS and cells were ®xed with 4% (w/v) paraformaldehyde, 4% (w/v) sucrose in PBS for 20 min at room temperature. Prior to incubation at 708C in 2£ SSC for 15 min, cells were washed twice with PBS for 5 min. After rinsing once again with PBS followed by 2£ SSC, the EBs were ®xed again for 5 min and the washing step with PBS and 2£ SSC was repeated. The cells were subsequently dehydrated at room temperature for 2 min each in 50%, 70%, 95% and twice in 100% ethanol. Prehybridization was performed in prehybridization buffer containing 5£ SSC, 5£ Denhardt's, 50% formamide, 250 mg/ml yeast-t-RNA, 250 mg/ml denatured salmon sperm DNA and 4 mM EDTA for 3 h in a humid chamber at 458C. Hybridization with digoxigeninlabeled sense and antisense probes against scleraxis (1 ng/ ml) was done in prehybridization buffer without salmon sperm DNA at 458C in a humid chamber overnight. After hybridization, specimen were washed twice with 2£ SSC for 15 min, once with 0.2£ SSC for 15 min and twice with 0.1£ SSC for 15 min at 458C and rinsed in PBS. The monoclonal antibody II-II6B3 against collagen II (diluted 1:20 in PBS) was applied, followed by incubation in a humidi®ed chamber for 1 h at 378C. Cells were washed three times with PBS at room temperature and FITC-conjugated sheep F(ab) fragments against digoxigenin (Boehringer, Mannheim, Germany) and Cy3-conjugated goat anti-mouse secondary antibodies (Dianova) for indirect detection of collagen II, both diluted 1:800 in PBS, were added. After incubation for 1 h at 378C, slides were washed three times in PBS and once in distilled water, embedded in Vectashield mounting medium and analyzed with the Axioskop¯uorescence microscope (Zeiss).
Hybridization probe
For in situ hybridization, we ampli®ed a fragment of scleraxis cDNA from RNA isolated from 16-day p.c. mouse limb buds following the protocol of RT±PCR as described above. The fragment was blunt end cloned into the plasmid vector pCR-BluntII-TOPO using the TOPO II cloning kit according to the manufacturer's protocol (Invitrogen, Groningen, Netherlands) and veri®ed by sequencing. Digoxigenin labeled RNA probes of either sense or antisense orientation of scleraxis were synthesized from linearized templates of the scleraxis PCR-product (see above) by in vitro transcription using the T7-or SP6-RNA polymerase following the protocol supplied by the manufacturer (Boehringer).
